Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

Evaluation of preclinical evidence prior to initiating early-phase clinical studies has typically been performed by selecting individual studies in a non-systematic process that may introduce bias. Thus, in preparation for a first-in-human trial of mesenchymal stromal cells (MSCs) for septic shock,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalu, Manoj M, Sullivan, Katrina J, Mei, Shirley HJ, Moher, David, Straus, Alexander, Fergusson, Dean A, Stewart, Duncan J, Jazi, Mazen, MacLeod, Malcolm, Winston, Brent, Marshall, John, Hutton, Brian, Walley, Keith R, McIntyre, Lauralyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2016
Materias:
Epidemiology and Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153252/
https://www.ncbi.nlm.nih.gov/pubmed/27870924
http://dx.doi.org/10.7554/eLife.17850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153252/
https://www.ncbi.nlm.nih.gov/pubmed/27870924
http://dx.doi.org/10.7554/eLife.17850

Ejemplares similares